5th China Pharmaceutical Innovation and Investment Conference to Convene in Suzhou on September 27, 2020
The 5th China Pharmaceutical Innovation and Investment Conference (hereinafter referred to as the “Venture Capital Conference”) will be grandly held in Suzhou Industrial Park from September 27 to 29, 2020. This year’s conference will closely revolve around current hot topics, with a deep focus on industrial policies, global pharmaceutical R&D trends, and investment and financing dynamics. It will comprehensively explore the development trends of global pharmaceutical innovation and jointly discuss new developments in biopharmaceutical investment cooperation.
The opening ceremony of the conference has been honored by the presence of Chen Deming, former Minister of Commerce and President of the China Association of Enterprises with Foreign Investment; Shang Fulin, Director of the Economic Committee of the National Committee of the Chinese People’s Political Consultative Conference (CPPCC) and former Chairman of the China Banking Regulatory Commission; Bi Jingquan, Deputy Director of the Economic Committee of the National Committee of the CPPCC and former Party Secretary and Deputy Director of the State Administration for Market Regulation; along with other leaders from national ministries and commissions, renowned domestic scientists, prominent entrepreneurs, and leading figures in finance and investment. These distinguished guests will provide in-depth interpretations and engage in lively discussions on the latest domestic and international policies regarding pharmaceutical innovation and investment trends, introduce new perspectives on innovative drug R&D directions, and jointly explore the new landscape of China’s pharmaceutical industry.
The conference has newly established the “ChiNext Forum,” which, together with the “STAR Market Forum” and the HKEX Innovative Companies Symposium, focuses on the entire process of pharmaceutical companies’ public listings. Distinguished representatives from the business divisions of the Hong Kong Exchanges and Clearing Limited (HKEX), the Shanghai Stock Exchange (SSE), and the Shenzhen Stock Exchange (SZSE) have been specially invited to present updates on the operations of their respective markets and to explain new reform policies. With the three major stock exchanges gathering in Suzhou, they will jointly illustrate the dynamic landscape of China’s capital markets driving the robust growth of the pharmaceutical industry.
Affected by the pandemic, the international sessions of this conference were held in the form of online cloud roadshows. On September 21 and 22, the Netherlands session and Canada session, hosted respectively by the Embassy of the Kingdom of the Netherlands in China and the Consulate General of Canada in Shanghai, were successfully conducted. Innovative projects from the Netherlands and Canada sparked lively discussions on frontier topics and achievements in international drug R&D. The showcased projects covered therapeutic areas such as oncology, neurodegenerative diseases, autoimmune diseases, and cardiovascular and cerebrovascular diseases, as well as cutting-edge technologies including multi-gene diagnostic techniques and drug delivery platforms. These presentations garnered significant attention and acclaim from participating enterprises and attendees both domestically and internationally. The successful online holding of the international sessions unveiled the highlights of this Venture Capital Conference in advance, bringing new opportunities and hope for corporate investment and collaboration in the post-pandemic era, while also creating more options for investment institutions.
On September 27, 2020, the 5th China Pharmaceutical Innovation and Investment Conference will meet you in Suzhou.
Scan the QR code and follow the VC Conference Service Account to stay updated with the latest conference information.
Scan the QR code above to register directly for the conference.
VCBeat,China News Service, Caixin Health, Health News, China Pharmaceutical News, Health Times, International Financial News, 21st Century Business Herald, The Epoch Weekly, Yicai Daily, China Securities Journal, Financial Times, National Business Daily, China Business Journal, Southern Weekly, Science and Technology Daily; International/Industry Media: JRJ.com.cn, Caijing.com.cn, Cailianshe, Huxiu, 36Kr, Jiemian News, The Paper; New Media: Drug Discovery Coalition, PharmCube, BestMed, LinkMed, Insight Database, EO Healthcare, Huihui Yaoka, CPhI Online, 17Talk, Pharma Time, New Observations on Drug Regulation, ChemAdder, Cyzone, Cass Club, BioExplorer, Beike She, The Intellectuals, YaoDu, Shiyi Medical Health, Clarivate, Jian Shi Ju, CHC Medical Media, Mergermarket, Blue Rainbow, MedPartner, Shangtu Pharma News, New Health World, Bioon, MedSci